VIROPHARMA INC: cash_and_equivalents

Value{"amount": 426732000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2011-01-01)
Statuscurrent
EntityVIROPHARMA INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-12-347761 · Open the official SEC filing →
Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000946840/cash-and-equivalents/2011-01-01 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f07db177-498f-4c09-96cd-7ffed3ca1eb6

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies